Yahoo Search Busca da Web

Entrar

Resultado da Busca

  1. www.modernatx.comPioneering mRNA technology - Moderna

    Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines.

  2. www.modernatx.com › pt-BRPioneering mRNA technology - Moderna

    Acreditamos que a nossa plataforma de mRNA é capaz de resolver os maiores desafios de saúde do mundo, desde doenças que afetam milhões até enfermidades ultrarraras que acometem dezenas de pessoas, com desenvolvimento de medicamentos personalizados chegando ao nível individual. SAIBA MAIS SOBRE O mRNA.

    • 200 Tech Square, Cambridge, 02139, MA
    • latammedinfo@modernatx.com
    • 18,7B

  3. pt.wikipedia.org › wiki › Moderna_TherapeuticsModerna Therapeutics – Wikipédia, a enciclopédia livre

    Moderna, Inc. é uma empresa de biotecnologia dos EUA com sede em Cambridge, Massachusetts, focada na descoberta e desenvolvimento de medicamentos com base no RNA mensageiro (mRNA).

  4. www.modernatx.com › about-us › our-storyOur Story - Moderna

    Moderna initiates first-in-human dosing for mRNA-1653, a combination vaccine with the potential to protect against more than one disease – human metapneumovirus (hMPV virus) and parainfluenza virus.

  5. en.wikipedia.org › wiki › ModernaModerna - Wikipedia

    Moderna, Inc. (/ m ə ˈ d ɜːr n ə / mə-DUR-nə) is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response .

  6. news.modernatx.com › news › news-detailsModerna Advances Multiple Vaccine Programs to Late-Stage ...

    27 de mar. de 2024 · Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases.

  7. news.modernatx.com › news › news-detailsModerna Achieves Positive Interim Results from Phase 3 Trial ...

    26 de mar. de 2024 · Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases.